Plans reimburse for emerging

April 15, 2011
But the projected high cost of these agents will drive plans to place them on higher tiers, according to a new report.

To read this article, go to therapies.

To read more about multiple sclerosis, go to multiple sclerosis.

For more information, go to

To comment on this subject, go to